Trulieve Cannabis Corp. balance sheet
At the end of fiscal 2025, Trulieve Cannabis Corp. had total assets of $2.70bn, total liabilities of $1.55bn and shareholders' equity of $1.14bn. It held $256m in cash against $141m of debt: net cash of $115m.
Balance sheet
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 92 | 147 | 227 | 207 | 201 | 239 | 256 | 325 |
| Receivables | — | 0 | 9 | 7 | 7 | 8 | 10 | 4 |
| Inventory | — | 98 | 212 | 277 | 213 | 231 | 242 | 187 |
| Total current assets | — | 261 | 524 | 594 | 477 | 605 | 563 | 565 |
| Goodwill | 7 | 67 | 765 | 791 | 484 | 484 | 484 | 326 |
| Total assets | — | 810 | 3,411 | 3,400 | 2,729 | 2,870 | 2,696 | 2,077 |
| Accounts payable | — | 9 | 15 | 16 | 28 | 20 | 27 | — |
| Deferred revenue (current) | — | 7 | 7 | 9 | 1 | 8 | 9 | 7 |
| Total current liabilities | — | 76 | 169 | 210 | 115 | 138 | 127 | 95 |
| Long-term debt | — | 4 | 463 | 542 | 363 | 365 | 137 | 196 |
| Total debt | 0 | 6 | 480 | 555 | 368 | 368 | 141 | 200 |
| Total liabilities | — | 362 | 1,263 | 1,473 | 1,320 | 1,621 | 1,553 | 1,312 |
| Shareholders' equity | 133 | 448 | 2,147 | 1,928 | 1,409 | 1,249 | 1,143 | 766 |
| Net debt (negative = net cash) | −92 | −141 | 253 | 348 | 167 | 129 | −115 | −125 |
| Shares outstanding | — | 120m | 181m | 186m | 186m | 191m | 192m | 192m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 9 | 8 | 10 | 11 | 10 | 10 | 14 | 4 |
| Inventory | 221 | 231 | 239 | 241 | 243 | 242 | 242 | 187 |
| Total current assets | 603 | 605 | 649 | 711 | 756 | 563 | 653 | 565 |
| Goodwill | 484 | 484 | 484 | 484 | 484 | 484 | 484 | 326 |
| Total assets | 2,874 | 2,870 | 2,888 | 2,922 | 2,942 | 2,696 | 2,782 | 2,077 |
| Accounts payable | — | 20 | — | — | — | 27 | — | — |
| Deferred revenue (current) | 6 | 8 | 9 | 8 | 9 | 9 | 10 | 7 |
| Total current liabilities | 137 | 138 | 137 | 124 | 124 | 127 | 124 | 95 |
| Long-term debt | 364 | 365 | 365 | 366 | 366 | 137 | 196 | 196 |
| Total debt | 364 | 365 | 365 | 366 | 366 | 137 | 196 | 196 |
| Total liabilities | 1,566 | 1,621 | 1,669 | 1,712 | 1,755 | 1,553 | 1,633 | 1,312 |
| Shareholders' equity | 1,300 | 1,249 | 1,219 | 1,209 | 1,186 | 1,143 | 1,149 | 766 |
| Shares outstanding | 189m | 191m | 191m | 191m | 191m | 192m | 192m | 192m |
Compare with peers
- Prestige Consumer Healthcare Inc. balance sheet
- ANI Pharmaceuticals Inc balance sheet
- Harmony Biosciences Holdings, Inc. balance sheet
- Indivior Pharmaceuticals, Inc. balance sheet
- Axsome Therapeutics, Inc. balance sheet
Head to head: PBH vs TRLVANIP vs TRLVHRMY vs TRLVINDV vs TRLV
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies